| Patients | Disease duration | Urinary 8-OHdG (ng/mg Cr) | DAS28 | ACPA (U/ml) | Medications |  | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  | Baseline | 4w | 8w | 12w | Baseline | 4w | 8w | 12w | Baseline | 4w | 8w | 12w | MTX (mg/w) | Duration | Abatacept (mg/4w) | Duration | Response | ||
Patient number | Sex | Age | Y | M | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Y | M | Â | Y | M | Â |
1 | F | 67 | 3 | 2 | 10.1 | 10.0 | 7.7 | 6.0 | 3.28 | 2.45 | 2.40 | 1.94 | 300 | 204 | 254 | 226 | 6 | 2 | 0 | 500 | 1 | 2 | good |
2 | F | 69 | 5 | 0 | 18.0 | 16.2 | 12.0 | 11.5 | 2.90 | 2.95 | 2.53 | 2.62 | <0.6 | <0.6 | <0.6 | <0.6 | 4 | 2 | 1 | Â | Â | Â | non-response |
3 | F | 76 | 11 | 0 | 11.0 | 8.1 | 7.8 | 7.8 | 4.61 | 3.71 | 3.28 | 3.01 | 52.4 | 47.2 | 58.0 | 56.6 | 6 | 3 | 0 | Â | Â | Â | good |
4 | F | 51 | 2 | 1 | 11.4 | 11.3 | 9.1 | 9.4 | 3.00 | 2.79 | 2.86 | 2.30 | <0.6 | <0.6 | <0.6 | <0.6 | 6 | 1 | 6 | Â | Â | Â | moderate |
5 | F | 41 | 2 | 0 | 10.9 | 9.9 | 11.3 | 10.0 | 4.55 | 3.43 | 3.06 | 3.13 | 6.9 | 6.2 | 9.2 | 14.5 | none | good | |||||
6 | F | 42 | 2 | 2 | 15.3 | 12.6 | 11.6 | 10.8 | 4.63 | 4.03 | 2.44 | 2.57 | <0.6 | <0.6 | <0.6 | <0.6 | 6 | 1 | 4 | Â | Â | Â | good |
7 | F | 86 | 5 | 0 | 10.0 | 6.5 | 7.1 | 7.1 | 4.67 | 3.79 | 3.78 | 3.00 | 0.8 | <0.6 | <0.6 | <0.6 | none | good | |||||
8 | F | 40 | 10 | 0 | nd | nd | 3.9 | 4.9 | 2.88 | 1.25 | 1.50 | 0.99 | 13.5 | 14.5 | 15.4 | 16.8 | 6 | 2 | 2 | Â | Â | Â | good |
9 | F | 41 | 2 | 1 | 8.7 | 7.7 | 7.3 | 9.0 | 5.38 | 4.35 | 4.37 | 4.22 | 34.3 | 36.4 | 57.6 | 65.7 | 8 | 1 | 6 | Â | Â | Â | moderate |
10 | M | 55 | 2 | 3 | 9.3 | 8.3 | 9.7 | 11.5 | 4.62 | 3.44 | 3.28 | 3.06 | 532 | 258 | 299 | 223 | 6 | 1 | 8 | Â | Â | Â | good |
11 | F | 56 | 2 | 0 | 12.0 | 8.2 | 10.8 | 10.9 | 5.47 | 5.22 | 5.06 | 4.16 | <0.6 | <0.6 | <0.6 | <0.6 | Â | Â | Â | 500 | 0 | 8 | good |
12 | M | 40 | 2 | 1 | 5.2 | 4.9 | 4.9 | 6.4 | 1.95 | 1.96 | 1.52 | 1.59 | <0.6 | <0.6 | <0.6 | <0.6 | 6 | 1 | 4 | Â | Â | Â | non-response |
13 | F | 64 | 13 | 0 | nd | 8.1 | 11.2 | 9.0 | 2.72 | 2.14 | 2.32 | 2.21 | 490 | 299 | 266 | 256 | 4 | 7 | 0 | Â | Â | Â | non-response |
14 | F | 58 | 2 | 0 | 10.7 | 8.4 | 8.5 | 10.5 | 3.21 | 3.03 | 2.93 | 3.04 | <0.6 | <0.6 | <0.6 | <0.6 | 6 | 1 | 2 | Â | Â | Â | non-response |
15 | F | 74 | 3 | 0 | 6.5 | 6.8 | 5.7 | 5.3 | 2.91 | 2.52 | 2.30 | 1.30 | <0.6 | <0.6 | <0.6 | <0.6 | none | good | |||||
16 | F | 69 | 0 | 8 | 7.6 | 6.5 | 8.6 | 5.4 | 4.07 | 2.78 | 2.54 | 0.99 | 2 | 3.7 | <0.6 | 1.9 | none | good | |||||
17 | M | 42 | 0 | 9 | 7.9 | 5.7 | 6.6 | 7.2 | 3.25 | 2.03 | 2.27 | 1.11 | <0.6 | <0.6 | <0.6 | <0.6 | 6 | Â | 6 | Â | Â | Â | good |
18 | F | 49 | 0 | 5 | 10.6 | 8.5 | 7.2 | 9.3 | 4.91 | 3.46 | 2.83 | 1.17 | <0.6 | <0.6 | <0.6 | <0.6 | none | good | |||||
19 | F | 57 | 0 | 10 | 9.5 | 9.4 | 9.2 | 10.7 | 3.38 | 2.87 | 2.50 | 1.82 | <0.6 | <0.6 | <0.6 | <0.6 | none | good | |||||
20 | F | 41 | 0 | 8 | 5.2 | 5.0 | 4.4 | 3.8 | 4.20 | 2.29 | 2.91 | 0.99 | <0.6 | <0.6 | <0.6 | <0.6 | none | good |